<DOC>
	<DOCNO>NCT01076153</DOCNO>
	<brief_summary>The investigator hypothesize Klacid modify release ( MR ) shorten symptom recovery time Thai patient upper low respiratory tract infection .</brief_summary>
	<brief_title>Recovery Time Thai Patients With Upper Lower Respiratory Tract Infections Treated With Klacid MR</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>Patients upper low respiratory tract infection . Patient male female â‰¥ 18 year age . Known hypersensitivity previously intolerant macrolides . Illness severe enough warrant hospitalization parenteral therapy . Concomitant use follow medication : Drugs metabolize CYP3A isozyme : alprazolam , astemizole , carbamazepine , cilostazol , cisapride , cyclosporin , disopyramide , ergot alkaloid , lovastatin , methylprednisolone , midazolam , omeprazole , oral anticoagulant ( e.g . warfarin ) , pimozide , quinidine , rifabutin , sildenafil , simvastatin , tacrolimus , terfenadine , triazolam vinblastine . Drugs metabolize isozymes within CYP450 system : phenytoin , theophylline valproate . Colchicine Digoxin Some antiretrovirals : zidovudine ritonavir . Severe immunodeficiency chronic disease condition . Renal hepatic impairment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Post-marketing observational study</keyword>
	<keyword>Upper low respiratory tract infection</keyword>
	<keyword>Klacid MR</keyword>
</DOC>